MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'alan schatzberg;'. Tue, 04 May 2010 18:45:59 +0100 http://www.medworm.com/index.php?rid=3398863&cid=t_342059_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F03%2Fdr-pangloss-as-nih-institute-director.html DR. PANGLOSS AS NIH INSTITUTE DIRECTORJAMA is out today with a Commentary by Dr. Thomas Insel, Director of the National Institute of Mental Health. Using indirection, Dr. Insel has risen to the defense of seven academic psychiatrists on whom an ethical searchlight has been trained for the past several years by Senator Grassley and others. With ludicrous optimism and a series of straw man discussions, Dr. Insel makes the case that things are not really as bad as they seemed to be or, if they were, then other specialty physicians were doing much the same things. Dr. Insel needs to recalibrate his ethical compass.Why is an NIH Institute Director issuing this apologia for the corruption of academic psychiatry? Does he not have better things to do, such as ensuring that longstanding NIH regulat... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=3398863 Wed, 24 Mar 2010 02:42:00 +0100 3398863 http://www.medworm.com/index.php?rid=3194016&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrMwmpyevORk%2F In his ongoing probe of conflicts of interest involving academic researchers, US Senator Chuck Grassley is now asking the National Institutes of Mental Health director Tom Insel to provide phone records, email and calendar since early 2009, along with correspondence from NIMH staffers in response to Grassley’s investigations. For the past two years, Grassley has pursued conflicts in which academic researchers accept funding from the NIH and industry, and instances where their universities have failed to monitor or report payments. According to current NIH regulations, payments above $10,000 should be reported. In his Jan. 20 letter, Grassley cites several examples… The psychiatry chair at Emory University, Charles Nemeroff, failed to report hundreds of thousands of dollars in p... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3194016 Thu, 21 Jan 2010 12:11:26 +0100 3194016 http://www.medworm.com/index.php?rid=2375958&cid=t_342059_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F04%2Finstitute-of-medicine-report-on.html Today we saw a new marker laid down in the arena called Conflict of Interest (COI). The Institute of Medicine of the National Academy of Sciences issued a report of its Committee on Conflict of Interest in Medical Research, Education and Practice. The report is comprehensive, even exhaustive, running to 353 pages. Gardner Harris in the New York Times today calls it “scolding,” “stinging,” and “damning.” The recommendations go well beyond any proposed in the recent past by medical schools or by other professional organizations. The NYT quoted David Rothman, president of the Institute on Medicine as a Profession at Columbia University: “With the I.O.M.’s endorsement, issues that were once controversial now are indisputable. Conflicts of interest in medicine are no longer acce... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2375958 Wed, 29 Apr 2009 00:40:00 +0100 2375958 http://www.medworm.com/index.php?rid=2013691&cid=t_342059_140_f&fid=35448&url=http%3A%2F%2Fseemedlikeagoodideathetime.com%2F2008%2F12%2F04%2Fyeah-but%2F …does the average patient even know to check, or what it means? I’ll take this very sad example as a “no” “I don’t care at all. I really, truly don’t,” said Judith Ursitti of Dover, Mass., whose son, Jack, 8, has autism. “When I take Jack to a specialist, I research their level of knowledge and how [...] (Source: bipolar chicks blogging) bipolar chicks blogging blogs http://www.medworm.com/rss/comments.php?id=2013691 Fri, 05 Dec 2008 02:33:16 +0100 2013691 http://www.medworm.com/index.php?rid=1871104&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F416746621%2F For the past several months, the US Senate Finance Committee has been investigating undisclosed conflicts of interest involving academic researchers who receive NIH grants and pharma funding. At issue is whether universities are fulfilling their requirements to adequately monitor these disclosures in an effort to maintain scientific integrity and objectivity (back story here, here, here, here and here. Nature Medicine spoke with Chuck Grassley, the ranking Republican on the committee, about the probe. This is an excerpt… Nature Medicine:What are you hoping to accomplish? Grassley: NIH gives $24 billion worth of grants…The law requires the universities to have their researchers report outside income. We found out the law wasn’t being followed. The universities were not doi... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1871104 Fri, 10 Oct 2008 12:23:26 +0100 1871104 http://www.medworm.com/index.php?rid=1853828&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F412282361%2F For several years, Charles Nemeroff assured Emory University, where he chaired the psychiatry department, that he wouldn’t accept more than $10,000 in consulting fees from Glaxo, since he was the primary investigator on an NIH-funded grant for research into a Glaxo drug. Why? Since 1995, an NIH regulation has required scientists to report to their universities any “significant financial interests” they hold in research projects financed by the agency. Those are defined as income or equity interest of $10,000 from a company or 5-percent ownership of its stock. The universities, in turn, are required to tell the NIH whether they were able to manage or eliminate the conflicts in order to avoid bias in the research findings (here are the rules). And anxious Emory officials, who condu... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1853828 Mon, 06 Oct 2008 00:37:31 +0100 1853828 http://www.medworm.com/index.php?rid=1852738&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F410375229%2F Why was Charles Nemeroff, the well-known psychiatry department chair at Emory University, anxious about an e-mail from The New York Times in August? Could it be that word had leaked Emory was concerned about an ongoing probe by the Senate Finance Committee into disclosures of NIH and pharma funding to academic researchers? Was Nemeroff next? By then, the committee was investigating Stanford University’s Alan Schatzberg, Harvard University’s Joe Biederman, Brown University’s Martin Keller, University of Texas’ Karen Wagner and John Rush, and Melissa DelBello at the University of Cincinnati. Yesterday, we noted Nemeroff wrote an angry memo to the associate dean at Emory’s School of Medicine, who questioned pharma ties to an annual event he runs for psychiatry re... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1852738 Fri, 03 Oct 2008 15:55:23 +0100 1852738 http://www.medworm.com/index.php?rid=1851212&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F409343727%2F The ongoing investigation by the Senate Finance Committee seems to be making some universities a bit, well, sensitive to the activities undertaken by faculty members. You may recall that Chuck Grassley, the commitee’s ranking Republican, is probing pharma and NIH funding given academic researchers - particularly psychiatrists - and whether any conflicts are properly disclosed. So far, the committee has singled out Stanford University’s Alan Schatzberg, Harvard University’s Joe Biederman, Brown University’s Martin Keller, University of Texas’ Karen Wagner and John Rush, and Melissa DelBello at the University of Cincinnati. Charles Nemeroff, the well-known psychiatry chairman at Emory University, has not made the list, but the school appears, nonetheless, to be ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1851212 Thu, 02 Oct 2008 15:19:44 +0100 1851212 http://www.medworm.com/index.php?rid=1837488&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F405499147%2F Such a busy pharma world and so little time to keep up, yes? Like you, we always poke around for items of interest, and so we thought we would point out a few you may enjoy from the past week. Think of it as a little bit of catching up. Meanwhile, we hope your weekend is enjoyable and look forward to seeing you again tomorrow… The droll Jim Edwards points out that Sanofi-Aventis has become the latest drugmaker to get into the online video game business, or advergames. This one is for the ubiquitous Ambien Cr sleeping pill, and the game is called “Silence Your Rooster.” You can check it out here. By striking a deal to fill certain generics for free as part of a trial with Caterpillar, Wal-Mart is subtly undermining the economic model used so well by pharmacy benefit manage... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1837488 Sun, 28 Sep 2008 23:34:00 +0100 1837488 http://www.medworm.com/index.php?rid=1788922&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F389612650%2F This time, the ranking Republican on the US Senate Finance Committee is fingering Karen Wagner, a researcher at the University of Texas who worked on a National Institutes of Health study involving Glaxo’s Paxil antidepressant, who allegedly did not disclose more than $150,000 in consulting and speaking fees she received from the drugmaker, according to The Wall Street Journal. Grassley cited Wagner after comparing records from Glaxo and the university. Between 2000 and 2008, she was involved in an NIH study on the use of Paxil to treat teenage depression and another study on teen anxiety, the paper writes. The university’s legal counsel tells the paper they will look for any discrepancies in Wagner’s disclosure reports, Wagner did not respond to the paper’s request... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1788922 Thu, 11 Sep 2008 12:27:17 +0100 1788922 http://www.medworm.com/index.php?rid=1779680&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F386609971%2F For the first time since Stanford University last month reassigned his National Institutes of Health grant to another principal investigator (look here), the chair of the school’s psychiatry department is responding to the episode, which actually began earlier this year when the US Senate Finance Committee named him as an example of federally funded academics with conflicts of interest. You may recall that Schatzberg, who is also president-elect of the American Psychiatric Association, owns about $6 million in stock in Corcept Therapeutics, which is studying the development of mifepristone for treating psychotic depression. He is also a co-patent holder for the drug and he received an NIH grant to oversee the research. Stanford insisted he had no role in dealing with patients or anal... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1779680 Mon, 08 Sep 2008 11:50:15 +0100 1779680 http://www.medworm.com/index.php?rid=1675137&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F352794956%2F The Senate Finance Committee is intensifying its investigation into research grants and conflicts of interest are managed by the National Institutes of Health and universities, whose academic researchers receive both NIH funding and have ties to drugmakers. Yesterday, though, Stanford University and its psychiatry department chair, Alan Schatzberg, came under special scrutiny - again. You may recall Schatzberg owns about $6 million in stock in Corcept Therapeutics, which is studying the development of mifepristone for treating psychotic depression. He is also a co-patent holder for the drug and he received an NIH grant to oversee the research. In response to the charges that Schatzberg failed to properly disclose this tangled web, Stanford issued a statement defending Schatzberg by saying,... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1675137 Fri, 01 Aug 2008 16:47:22 +0100 1675137 http://www.medworm.com/index.php?rid=1668704&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F350601005%2F Last month, the US Senate Finance Committee charged that Stanford University failed to properly monitor alleged conflicts of interest involving Alan Schatzberg, who chairs the psychiatry department and owns about $6 million in stock in Corcept Therapeutics, which is studying the development of mifepristone, or RU-486, for treating psychotic depression. In addition to his stock holdings, Schatzberg is also a co-patent holder for the drug, which is best known for inducing abortion, and he received a grant from the National Institutes of Health to oversee the research. In response to the charges that Schatzberg failed to properly disclose this tangled web, Stanford issued a statement defending Schatzberg by saying, among other things, that all conflicts were properly disclosed. Schatzberg &#8... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1668704 Wed, 30 Jul 2008 15:40:27 +0100 1668704 http://www.medworm.com/index.php?rid=1655670&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F345833615%2F The ranking Republican on the Senate Finance Committee wants the National Institutes of Health to revoke grants to academic scientists who fail to report financial conflicts of interest to their institutions, the Iowa Senator tells The Chronicle of Higher Education. His remarks come after targeting Harvard University, Stanford University and the University of Cincinnati, because some academics underreported their own financial interests in research projects supported by the NIH. Institutions are required by federal regulation to report the existence of those conflicts to the agency. Grassley is seeking info from 20 other institutions about financial conflicts among their scientists, including Brown University’s Martin Keller, and the American Psychiatric Association. Since 1995, an N... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1655670 Fri, 25 Jul 2008 17:01:05 +0100 1655670 http://www.medworm.com/index.php?rid=1622999&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F335299832%2F Among the 30 or so physicians at two dozen universities that the Senate Finance Committee is probing concerning disclosure of grants from drugmakers is Martin Keller, a psychiatrist at Brown University who is a controversial figure for his role in studying Glaxo’s Paxil antidepressant. The committee, according to sources familiar with the investigation, sent a letter to Brown as part of its investigation. We are awaiting a reply from Brown and will update you shortly. In recent weeks, the committee has acknowledged focusing on three academic psychiatrists - Harvard University’s Joe Biederman, Stanford University’s Alan Schatzberg and the University of Cincinnati’s Melissa DelBello. Last week, Chuck Grassley, the ranking Republican on the committee, also asked the Am... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1622999 Mon, 14 Jul 2008 18:09:11 +0100 1622999 http://www.medworm.com/index.php?rid=1561298&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F324104221%2F Last week, the Senate Finance Committee targeted yet another academic for failing to fully disclose potential conflicts involving research funding provided by drugmakers and other financial holdings. The example, which singled out Stanford University’s Alan Schatzberg, is part of a larger investigation into academics who receive funding from both the NIH and pharma for possible violations of federal regulations. At issue are whether universities and NIH are adequately policing disclosures in an effort to maintain scientific integrity and objectivity. In response to the probe, the NIH disclosed it would tighten oversight, but the story is just beginning. Eric Campbell, an associate professor at the Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School,... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1561298 Tue, 01 Jul 2008 14:36:45 +0100 1561298 http://www.medworm.com/index.php?rid=1543925&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F319993115%2F In response to sustained public pressure, the National Institutes of Health is now getting set to tighten its oversight on grants awarded academic researchers, whose institutions are required to report any conflicts of interest. Recent examples uncovered by the Senate Finance Committee, however, have embarrassed the NIH and several universities, most notably Harvard University. Over the past several months, the committee has disclosed instances where academic researchers at Harvard, Stanford University and the University of Cincinnatti accepted funding from both the NIH and various drugmakers, but failed to fully disclose industry payments. Universities are supposed to monitor researchers and the NIH is supposed to monitor the universities for conflicts involving payments exceeding $10,000... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1543925 Wed, 25 Jun 2008 21:03:01 +0100 1543925 http://www.medworm.com/index.php?rid=1543928&cid=t_342059_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F319828349%2F The US Senate Finance Committee charges that Stanford University failed to properly monitor alleged conflicts of interest involving Alan Schatzberg, who chairs the psychiatry department at Stanford University and who owns about $6 million in stock in Corcept Therapeutics, which that participates in a National Institutes of Health study he oversees. This is the latest such case involving high-profile academics, who receive funding from both the NIH and industry, to be investigated by Chuck Grassley, the ranking committee Republican, for possible violations of federal regulations. At issue are whether universities are adequately policing disclosures in an effort to maintain scientific integrity and objectivity. Earlier this month, he targeted three Harvard University psychiatrists, including... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1543928 Wed, 25 Jun 2008 16:34:27 +0100 1543928